322 related articles for article (PubMed ID: 23811604)
21. LOX-1 receptor: A potential link in atherosclerosis and cancer.
Balzan S; Lubrano V
Life Sci; 2018 Apr; 198():79-86. PubMed ID: 29462603
[TBL] [Abstract][Full Text] [Related]
22. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.
Mattaliano MD; Huard C; Cao W; Hill AA; Zhong W; Martinez RV; Harnish DC; Paulsen JE; Shih HH
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1329-37. PubMed ID: 19279231
[TBL] [Abstract][Full Text] [Related]
23. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.
Ou HC; Chou WC; Hung CH; Chu PM; Hsieh PL; Chan SH; Tsai KL
Environ Toxicol; 2019 Jul; 34(7):825-835. PubMed ID: 30963716
[TBL] [Abstract][Full Text] [Related]
24. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH
Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724
[TBL] [Abstract][Full Text] [Related]
25. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
Mehta JL
Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
[TBL] [Abstract][Full Text] [Related]
26. Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1.
Morawietz H; Duerrschmidt N; Niemann B; Galle J; Sawamura T; Holtz J
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():9S-12S. PubMed ID: 12193044
[TBL] [Abstract][Full Text] [Related]
27. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.
Lu J; Yang JH; Burns AR; Chen HH; Tang D; Walterscheid JP; Suzuki S; Yang CY; Sawamura T; Chen CH
Circ Res; 2009 Mar; 104(5):619-27. PubMed ID: 19150883
[TBL] [Abstract][Full Text] [Related]
28. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
Singh S; Gautam AS
Curr Atheroscler Rep; 2019 Jul; 21(10):38. PubMed ID: 31350594
[TBL] [Abstract][Full Text] [Related]
29. Lectin-like oxidized low-density lipoprotein receptor-1-mediated autophagy in human granulosa cells as an alternative of programmed cell death.
Duerrschmidt N; Zabirnyk O; Nowicki M; Ricken A; Hmeidan FA; Blumenauer V; Borlak J; Spanel-Borowski K
Endocrinology; 2006 Aug; 147(8):3851-60. PubMed ID: 16690797
[TBL] [Abstract][Full Text] [Related]
30. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway.
Chen B; Li J; Zhu H
Vascul Pharmacol; 2016 Oct; 85():1-10. PubMed ID: 26297684
[TBL] [Abstract][Full Text] [Related]
31. The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells.
Li L; Renier G
Atherosclerosis; 2009 May; 204(1):40-6. PubMed ID: 18801483
[TBL] [Abstract][Full Text] [Related]
32. Ghrelin inhibits oxLDL-induced inflammation in RAW264.7 mouse macrophages through down-regulation of LOX-1 expression via NF-κB signaling pathway.
Sun N; Wang H; Wang L
Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):57-61. PubMed ID: 26950452
[TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.
Hossain E; Ota A; Karnan S; Takahashi M; Mannan SB; Konishi H; Hosokawa Y
Mol Cell Biochem; 2015 Feb; 400(1-2):29-40. PubMed ID: 25348362
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone decreased CD40/CD40L expression on human umbilical vein endothelial cells induced by oxidized low-density lipoprotein.
Jiang DQ; Chu LX; Liu ZY; Zhang SB
Clin Chim Acta; 2006 Aug; 370(1-2):94-9. PubMed ID: 16545355
[TBL] [Abstract][Full Text] [Related]
35. The lipid moiety 7-ketocholesteryl-9-carboxynonanoate mediates binding interaction of oxLDL to LOX-1 and upregulates ABCA1 expression through PPARγ.
Li J; Xiu Z; Wang R; Yu C; Chi Y; Qin J; Fu C; Matsuura E; Liu Q
Life Sci; 2017 May; 177():27-40. PubMed ID: 28377266
[TBL] [Abstract][Full Text] [Related]
36. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
Chen M; Masaki T; Sawamura T
Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130
[TBL] [Abstract][Full Text] [Related]
37. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.
Ou HC; Song TY; Yeh YC; Huang CY; Yang SF; Chiu TH; Tsai KL; Chen KL; Wu YJ; Tsai CS; Chang LY; Kuo WW; Lee SD
J Appl Physiol (1985); 2010 Jun; 108(6):1745-56. PubMed ID: 20203069
[TBL] [Abstract][Full Text] [Related]
38. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.
Chen J; Liu Y; Liu H; Hermonat PL; Mehta JL
Biochem J; 2006 Jan; 393(Pt 1):255-65. PubMed ID: 16173915
[TBL] [Abstract][Full Text] [Related]
39. No upregulation of lectin-like oxidized low-density lipoprotein receptor-1 in serum-deprived EA.hy926 endothelial cells under oxLDL exposure, but increase in autophagy.
Nowicki M; Zabirnyk O; Duerrschmidt N; Borlak J; Spanel-Borowski K
Eur J Cell Biol; 2007 Oct; 86(10):605-16. PubMed ID: 17643551
[TBL] [Abstract][Full Text] [Related]
40. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
Reiss AB; Anwar K; Wirkowski P
Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
